thromboxanes has been researched along with Pneumonia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atkins, BZ; Carpenter, AJ; Danielson, DS; Dixon, P; Fitzpatrick, CM; Petersen, RP | 1 |
Blair, KS; Blum, MG; Chang, AC; Christman, BW; Collins, BJ; Parker, RE; Pierson, RN; Zorn, GL | 1 |
Downey, GP; Hellewell, PG; Henson, PM; Worthen, GS | 1 |
3 other study(ies) available for thromboxanes and Pneumonia
Article | Year |
---|---|
Modified ultrafiltration attenuates pulmonary-derived inflammatory mediators in response to cardiopulmonary bypass.
Topics: Animals; Animals, Newborn; Blood Pressure; Bronchoalveolar Lavage Fluid; Cardiac Output; Cardiopulmonary Bypass; Down-Regulation; Hemofiltration; Inflammation Mediators; Interleukin-6; Interleukin-8; Pneumonia; Pulmonary Alveoli; Swine; Thromboxanes; Tumor Necrosis Factor-alpha; Vascular Resistance | 2010 |
Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection.
Topics: Acute Disease; Animals; Capillary Permeability; Graft Rejection; Humans; Hypertension, Pulmonary; Inflammation Mediators; Lung; Lung Transplantation; Oxygen Consumption; Pneumonia; Pulmonary Circulation; Swine; Thromboxanes; Vascular Resistance | 2001 |
Control of local blood flow in pulmonary inflammation: role for neutrophils, PAF, and thromboxane.
Topics: Animals; Complement C5a; Feedback; Female; Guinea Pigs; Hypoxia; In Vitro Techniques; Male; Neutrophils; Platelet Activating Factor; Pneumonia; Pulmonary Circulation; Rabbits; Regional Blood Flow; Thromboxanes; Vasoconstriction | 1991 |